Despite rapid advances in precision medicine and biomarkers, translating scientific progress into effective oncology research remains challenging. Access to molecular testing, study eligibility, research participation and patient-relevant outcomes shape how research is designed and evaluated, with challenges varying across cancer types.
This panel discussion brings together leaders representing breast, lung and pancreatic cancer communities to examine both shared and cancer-specific research challenges. By comparing experiences across these areas, the discussion will explore where gaps emerge between scientific innovation, research design and patient realities.
Panelists will examine how patient and community insights, supported by stronger collaboration among patient organizations, researchers, healthcare professionals and industry, can help identify barriers earlier and inform research priorities, study feasibility, eligibility criteria, patient engagement, endpoint selection and access to research.
Attendees will gain insight into:
How research challenges differ across breast, lung and pancreatic cancer
Where testing and eligibility requirements create avoidable participation barriers
How earlier patient input can identify protocol burdens and inform study design and endpoint selection
How to balance scientific rigor with feasibility and patient burden in oncology studies
How cross-sector collaboration can turn patient insights into more effective oncology research
This session offers a unique opportunity to hear directly from leaders across three distinct cancer communities and understand how their perspectives can inform future oncology research and clinical development strategies.
Register for this webinar to learn how patient insights and advocacy perspectives can help identify research gaps, strengthen clinical development strategies and better align oncology research with patient needs.
Who Should Attend
This webinar is designed for oncology professionals across nonprofit organizations, healthcare systems, research institutions and the pharma and biotech sectors in the following fields:
Clinical Research and Development
Oncology Research and Scientific Leadership
Clinical Operations and Trial Strategy
Biomarkers, Precision Medicine and Translational Research
Patient Engagement, Recruitment and Research Participation
Medical Affairs and Patient Outcomes
Patient Advocacy, Support and Community Engagement
Partnerships and cross-sector collaboration
Register free on Xtalks: https://xtalks.com/webinars/turn-patient-insights-into-stronger-oncology-research-strategies/
